Management Team

Paul J. Fitzpatrick
CEO

Paul brings to Advanced Catheter Therapies (ACT) 24 years of diverse, entrepreneurial business and healthcare experience with a proven track record of delivering results. His company, PJ Fitzpatrick Executive Advisory Group, provides interim and fractional C-level and board engagements to early stage and small companies.

Paul’s experience includes serving as Founder, CEO, President, Board Director, COO and EVP. He has completed over 20 M&A transactions with a combined value in excess of $100 million, and has been involved with numerous start-ups, turnarounds, roll-ups and integration of acquired companies with a range of public, private and venture-backed financing. With an in-depth knowledge of medical devices, clinical and patient care services, developing strategic alliances, multi-site and multi-state state operations, education and international recruiting and staffing, Paul brings a rich skill set and knowledge base to his role with ACT.

Prior to joining ACT, Paul was brought in to serve as interim Chief Executive Officer and Director of NeoMatrix, LLC, an early stage medical device company, by the company’s Investment Bank, Waveland Capital Group. He successfully developed a strategic operational and funding plan to turn around Neomatrix and take it from R&D to commercialization. He founded I-Medical Staffing, a U.S.-based healthcare staffing company that sourced, prepared, and employed highly experienced, internationally trained, English-speaking registered nurses for assignments into U.S. healthcare facilities. The company was merged with a large domestic staffing company in 2006.

Prior experience includes serving as Executive Vice President and COO and a start-up team member of Healthcare Innovations, Inc., a rehabilitation services company that was sold to a large, publicly traded company thanks to his efforts. Paul served as Corporate Vice President at Careline, Inc., an emergency medical services rollup company that had two public offerings raising $57 million and $75 million, respectively, and was eventually acquired for $258 million. He has also operated an emergency medical services consulting firm.

Paul is a graduate of the Daniel Freeman Hospital Paramedic School, earning his board certification as a National Registered Paramedic, and holds a degree in paramedic technology from Northeastern University in Boston where he served as an adjunct faculty member for 10 years.
Dirk V. Hoyns
Co-founder and Vice President of Product Development

Dirk brings 20+ years of successful product development & commercialization experience in the medical device and biotechnology fields to Advanced Catheter Therapies.

Dirk is president of Device Technologies, Inc. a medical device design consultancy and incubator. Since the company’s inception in 2001, he has helped numerous early-stage medical technology companies with their product development activities. His prior experience includes serving as staff engineer and patent officer with the Peripheral Technologies Division of C.R. Bard, where he led multi-disciplinary teams developing products for the interventional radiology & peripheral vascular markets, and with Sepracor, Inc. developing manufacturing of their membrane bioreactor program.

Dirk holds and has pending numerous U.S. patents in the fields of peripheral vascular, cardiology, biopsy, orthopedics and other minimally invasive and catheter-based technologies. Dirk is a graduate of Boston’s Wentworth Institute of Technology, with degrees in both Mechanical Design and Management Engineering.
C. Rex Teeslink, M.D.
Co-founder, Inventor and Scientific Advisor

Rex Teeslink, M.D. is a vascular and interventional radiologist with over 40 years of experience. He received his M.D. degree from Tulane University School of Medicine in New Orleans and completed his radiology residency at the University of Virginia in Charlottesville.

Dr. Teeslink began his practice in 1968 as Chief of Vascular and Interventional Radiology at the Medical College of Georgia, the Veterans Administration and three private hospitals in Augusta, Georgia. He served in this capacity for 30 years, and continues his medical practice through medical consulting companies.

Dr. Teeslink has been actively involved throughout his career in leading-edge technology and continues to assist in the design, development and implementation of numerous medical devices and X-ray equipment. Dr. Teeslink has served as medical director and consultant for several companies. He has been instrumental in helping develop many of the interventional procedures that are utilized today. Dr. Teeslink has always been involved in medical education endeavors, including training medical students, residents, fellows and post graduate physicians. A recognized expert in his field, he has shared his knowledge and experience at numerous medical conferences, both nationally and internationally.
F. Kevin Dye
Vice President of Finance and Operations and Director

Kevin is the CEO and owner of The Dye Group, Inc., a senior management business consulting business focused within the medical device industry. He has 31 years of experience in the industry. Prior to his current position he worked as the President of TEFTEC Corporation, a power wheelchair manufacturer; CEO of GenPhar, Inc., a biotech vaccine company; President of SwampCat, an insecticide repellent start up; and Alphamed, Incorporated, a company that developed and manufactured ambulatory infusion pumps.

Kevin spent 22 years working at C.R. Bard, Inc. Beginning in Accounting, he worked his way up to Controller of Productos Para el Cuidado de la Salud, S.A. de C.V., a Nogales, Sonora, Mexico maquilladora. Halfway through his time at Bard, he switched careers and became Operations Manager for Bard's all-silicone catheter manufacturing facility in Tucson, AZ. He then worked in supply chain management, becoming the Director of Global Logistics for Bard's Peripheral Technologies Division in Covington, GA.

Kevin has a BS in Accounting/Finance from Fairleigh Dickinson University - Madison, NJ.